UNITEFA   23945
UNIDAD DE INVESTIGACION Y DESARROLLO EN TECNOLOGIA FARMACEUTICA
Unidad Ejecutora - UE
artículos
Título:
Antiparasitic efficacy of a Ricobendazole controlled release formulation against Ancylostoma caninum and Trichuris sp intended for oral administration in dogs
Autor/es:
ALDROVANI A; PALMA S. D; ALEJANDRO PAREDES; DIB A; LANUSSE , C; ALLEMANDI D,; SANCHEZ BRUNI, S;
Revista:
Veterinaria (Montevideo)
Editorial:
Sociedad de Medicina Veterinaria del Uruguay
Referencias:
Lugar: Montevideo; Año: 2016 vol. 52 p. 11 - 21
ISSN:
0376-4362
Resumen:
The aim of this work was to evaluate the clinical oral efficacy in dogs of two different single doses (20 mg/kg and 10 mg/kg) of a controlled release (CR) Ricobendazole (RBZ) based formulation formulated within a lipid matrix of CetylAlcohol and compare it with those of one single dose RBZ immediate release (IR) formulation (20 mg/kg) and one Albendazole (ABZ) IR formulation (25 mg/kg)(3 consecutive doses q/24 h). Thirty naturally parasitised dogs with Ancylostomacaninum and Trichuris sp were randomly allocated to five groups (n=6). A pair-sample t- Test (p